Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
Drug candidates targeting amyloid-β (Aβ) pathology in Alzheimer's disease are in different phases of clinical trials. These treatments will probably be most effective in the earlier stages of the disease, befo...